• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA n339260 通过调控 miRNA30e-5p/TP53INP1 的表达在肝癌进展中发挥作用。

LncRNA n339260 functions in hepatocellular carcinoma progression via regulation of miRNA30e-5p/TP53INP1 expression.

机构信息

Department of Pathology, Tianjin Medical University, Tianjin, 300070, China.

Department of Pathology, General Hospital of Tianjin Medical University, Tianjin, 300052, China.

出版信息

J Gastroenterol. 2022 Oct;57(10):784-797. doi: 10.1007/s00535-022-01901-8. Epub 2022 Jul 8.

DOI:10.1007/s00535-022-01901-8
PMID:35802258
Abstract

BACKGROUND

Currently, the molecular mechanism of the interaction between lncRNAs and microRNAs (miRNAs) and the target of miRNAs in tumor vasculogenic mimicry (VM) formation have not been clarified. Our aim is to study the interaction between lncRNA n339260 and miRNA30e-5p in the formation of VM.

METHODS

Animal xenografts were established, 104 hepatocellular carcinoma (HCC) patients' frozen tissues were obtained and HCC cells in vitro were used to observe the role of n339260 in HCC progression.

RESULTS

In vivo experiment showed lncRNA n339260 promoted tumor growth and VM formation. LncRNA n339260 and miRNA30e-5p were found to be associated with VM formation, metastasis and survival time in HCC patients. In vitro experiment showed that LncRNA n339260 could inhibit miRNA30e-5p expression and TP53INP1 was found to be the downstream targets of miRNA30e-5p. Snail, MMP2, MMP9, VE-cadherin, vimentin and N-cadherin overexpression and the downregulation of TP53INP1 and E-cadherin were observed in HCCLM3 and HepG2 cells overexpressing lncRNA n339260 or in cells with decreased expression of miRNA30e-5p.

CONCLUSION

LncRNA n339260 promotes the development of VM, and lncRNA n339260 may enhance Snail expression by decreasing the expression of miRNA30e-5p, thereby reducing TP53INP1 expression. Therefore, a potential lncRNA n339260- miRNA30e-5p- TP53INP1 regulatory axis was associated with HCC progression.

摘要

背景

目前,lncRNA 与 microRNA(miRNA)之间的相互作用及其在肿瘤血管生成拟态(VM)形成中的靶标分子机制尚不清楚。本研究旨在探讨 lncRNA n339260 与 miRNA30e-5p 在 VM 形成中的相互作用。

方法

建立动物异种移植模型,获取 104 例肝癌(HCC)患者的冷冻组织和体外 HCC 细胞,观察 n339260 在 HCC 进展中的作用。

结果

体内实验表明 lncRNA n339260 促进肿瘤生长和 VM 形成。lncRNA n339260 与 miRNA30e-5p 与 HCC 患者的 VM 形成、转移和生存时间相关。体外实验表明,lncRNA n339260 可抑制 miRNA30e-5p 的表达,且 TP53INP1 是 miRNA30e-5p 的下游靶基因。在过表达 lncRNA n339260 或下调 miRNA30e-5p 表达的 HCCLM3 和 HepG2 细胞中,观察到 Snail、MMP2、MMP9、VE-cadherin、vimentin 和 N-cadherin 过表达,以及 TP53INP1 和 E-cadherin 下调。

结论

lncRNA n339260 促进 VM 的发展,lncRNA n339260 可能通过降低 miRNA30e-5p 的表达来增强 Snail 的表达,从而降低 TP53INP1 的表达。因此,lncRNA n339260-miRNA30e-5p-TP53INP1 调控轴可能与 HCC 的进展相关。

相似文献

1
LncRNA n339260 functions in hepatocellular carcinoma progression via regulation of miRNA30e-5p/TP53INP1 expression.长链非编码 RNA n339260 通过调控 miRNA30e-5p/TP53INP1 的表达在肝癌进展中发挥作用。
J Gastroenterol. 2022 Oct;57(10):784-797. doi: 10.1007/s00535-022-01901-8. Epub 2022 Jul 8.
2
Long noncoding RNA n339260 promotes vasculogenic mimicry and cancer stem cell development in hepatocellular carcinoma.长链非编码 RNA n339260 促进肝癌中的血管生成拟态和癌症干细胞发展。
Cancer Sci. 2018 Oct;109(10):3197-3208. doi: 10.1111/cas.13740. Epub 2018 Aug 14.
3
Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.长链非编码 RNA F11-AS1 通过与 microRNA-211-5p 结合来调控 NR1I3 抑制 HBV 相关肝细胞癌的进展。
J Cell Mol Med. 2020 Jan;24(2):1848-1865. doi: 10.1111/jcmm.14881. Epub 2019 Dec 27.
4
Androgen receptor suppresses vasculogenic mimicry in hepatocellular carcinoma via circRNA7/miRNA7-5p/VE-cadherin/Notch4 signalling.雄激素受体通过 circRNA7/miRNA7-5p/VE-cadherin/Notch4 信号通路抑制肝癌中的血管生成拟态。
J Cell Mol Med. 2020 Dec;24(23):14110-14120. doi: 10.1111/jcmm.16022. Epub 2020 Oct 28.
5
Silencing of long noncoding RNA LEF1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1.长链非编码 RNA LEF1-AS1 的沉默通过与 microRNA-136-5p/WNK1 的串扰防止肝细胞癌的进展。
J Cell Physiol. 2020 Oct;235(10):6548-6562. doi: 10.1002/jcp.29503. Epub 2020 Feb 18.
6
Long Non-Coding MALAT1 Functions as a Competing Endogenous RNA to Regulate Vimentin Expression by Sponging miR-30a-5p in Hepatocellular Carcinoma.长链非编码RNA MALAT1作为竞争性内源性RNA,通过海绵吸附miR-30a-5p调控肝细胞癌中波形蛋白的表达。
Cell Physiol Biochem. 2018;50(1):108-120. doi: 10.1159/000493962. Epub 2018 Oct 2.
7
Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway.lncRNA SBF2-AS1 的下调通过调节 miR-361-5p/TGF-β1 信号通路抑制肝癌细胞的增殖和迁移。
Aging (Albany NY). 2021 Aug 2;13(15):19260-19271. doi: 10.18632/aging.203248.
8
LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4.LncRNA SNHG7 通过调控 miR-122-5p 和 RPL4 促进肝癌细胞的增殖、迁移和侵袭。
Biomed Pharmacother. 2019 Oct;118:109386. doi: 10.1016/j.biopha.2019.109386. Epub 2019 Aug 30.
9
TP53INP1 inhibits hypoxia-induced vasculogenic mimicry formation via the ROS/snail signalling axis in breast cancer.TP53INP1 通过 ROS/snail 信号通路抑制乳腺癌缺氧诱导的血管生成拟态形成。
J Cell Mol Med. 2018 Jul;22(7):3475-3488. doi: 10.1111/jcmm.13625. Epub 2018 Apr 14.
10
Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.长链非编码 RNA AGAP2-AS1 作为竞争性内源性 RNA,通过海绵吸附 miR-16-5p 而上调 ANXA11 的表达,促进肝癌的增殖和转移。
J Exp Clin Cancer Res. 2019 May 14;38(1):194. doi: 10.1186/s13046-019-1188-x.

引用本文的文献

1
Regulation and Therapeutic Application of Long non-Coding RNA in Tumor Angiogenesis.长链非编码 RNA 在肿瘤血管生成中的调控作用及治疗应用。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241273239. doi: 10.1177/15330338241273239.
2
LncRNA SNHG25 Predicts Poor Prognosis and Promotes Progression in Osteosarcoma the miR-497-5p/SOX4 Axis.长链非编码 RNA SNHG25 通过 miR-497-5p/SOX4 轴预测骨肉瘤的不良预后和促进进展。
Comb Chem High Throughput Screen. 2024;27(5):725-744. doi: 10.2174/1386207326666230602122618.

本文引用的文献

1
MicroRNAs regulating SOX2 in cancer progression and therapy response.微小 RNA 在癌症进展和治疗反应中对 SOX2 的调控。
Expert Rev Mol Med. 2021 Sep 29;23:e13. doi: 10.1017/erm.2021.15.
2
lncRNA cytoskeleton regulator reduces non‑small cell lung cancer radiosensitivity by downregulating miRNA‑206 and activating prothymosin α.lncRNA 细胞骨架调节剂通过下调 miRNA-206 和激活胸腺素原α降低非小细胞肺癌的放射敏感性。
Int J Oncol. 2021 Nov;59(5). doi: 10.3892/ijo.2021.5268. Epub 2021 Sep 24.
3
Involvement of the circular RNA/microRNA/glucose-6-phosphate dehydrogenase axis in the pathological mechanism of hepatocellular carcinoma.
环状RNA/微小RNA/葡萄糖-6-磷酸脱氢酶轴在肝细胞癌病理机制中的作用
Hepatobiliary Pancreat Dis Int. 2021 Dec;20(6):530-534. doi: 10.1016/j.hbpd.2021.08.013. Epub 2021 Sep 9.
4
Long noncoding RNA SATB1-AS1 contributes to the chemotherapy resistance through the microRNA-580/ 2'-5'-oligoadenylate synthetase 2 axis in acute myeloid leukemia.长链非编码 RNA SATB1-AS1 通过 microRNA-580/2'-5'-寡聚腺苷酸合成酶 2 轴促进急性髓系白血病的化疗耐药性。
Bioengineered. 2021 Dec;12(1):6403-6417. doi: 10.1080/21655979.2021.1971508.
5
The emerging role of miR-200 family in metastasis: focus on EMT, CSCs, angiogenesis, and anoikis.miR-200 家族在转移中的新兴作用:专注于 EMT、CSCs、血管生成和失巢凋亡。
Mol Biol Rep. 2021 Oct;48(10):6935-6947. doi: 10.1007/s11033-021-06666-6. Epub 2021 Sep 12.
6
Crosstalk between lncRNAs and miRNAs in gastrointestinal cancer drug resistance.lncRNAs 和 miRNAs 在胃肠癌药物耐药性中的相互作用。
Life Sci. 2021 Nov 1;284:119933. doi: 10.1016/j.lfs.2021.119933. Epub 2021 Sep 8.
7
The Molecular Networks of microRNAs and Their Targets in the Drug Resistance of Colon Carcinoma.微小RNA及其靶标在结肠癌耐药中的分子网络
Cancers (Basel). 2021 Aug 28;13(17):4355. doi: 10.3390/cancers13174355.
8
Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma.血管生成拟态在肝细胞癌中的调控机制及治疗靶点。
Pharmacol Res. 2021 Apr;166:105507. doi: 10.1016/j.phrs.2021.105507. Epub 2021 Feb 18.
9
Long non-coding RNA ANRIL and its target microRNAs (microRNA-34a, microRNA-125a and microRNA-186) relate to risk stratification and prognosis in multiple myeloma.长链非编码 RNA ANRIL 及其靶 microRNAs(microRNA-34a、microRNA-125a 和 microRNA-186)与多发性骨髓瘤的风险分层和预后相关。
Hematology. 2021 Dec;26(1):160-169. doi: 10.1080/16078454.2021.1872275.
10
Multifunctional intracellular matrix metalloproteinases: implications in disease.多功能细胞内基质金属蛋白酶:疾病中的意义。
FEBS J. 2021 Dec;288(24):7162-7182. doi: 10.1111/febs.15701. Epub 2021 Jan 22.